Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
62°
Sunny
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Trevi Therapeutics, Inc. - Common Stock
(NQ:
TRVI
)
6.750
+0.460 (+7.31%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Trevi Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Unusual volume stocks are being observed in Tuesday's session.
March 11, 2025
In today's session, these stocks are experiencing unusual volume.
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
March 10, 2025
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday
March 10, 2025
Via
Benzinga
Trevi Therapeutics Reveals Positive Data From Mid-Stage Study For Chronic Cough Candidate, Stock Jumps
March 10, 2025
Trevi's Haduvio met the primary endpoint in a Phase 2a trial, showing a significant reduction in cough frequency with no serious adverse events reported.
Via
Benzinga
Trevi Therapeutics: Q4 Earnings Insights
March 20, 2024
Via
Benzinga
Earnings Outlook For Trevi Therapeutics
March 19, 2024
Via
Benzinga
Trevi Therapeutics's Earnings: A Preview
November 08, 2023
Via
Benzinga
Top movers in Monday's pre-market session
March 10, 2025
The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket
March 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 12, 2024
Via
Benzinga
Dow Tumbles 200 Points; Liquidity Services Shares Spike Higher
December 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Recap: Trevi Therapeutics Q1 Earnings
May 11, 2023
Via
Benzinga
Earnings Preview: Trevi Therapeutics
May 10, 2023
Via
Benzinga
Gold Falls Sharply; Adobe Shares Dip After Weak Revenue Outlook
December 12, 2024
Via
Benzinga
Nasdaq Down 50 Points; US Initial Jobless Claims Rise
December 12, 2024
Via
Benzinga
Why Is Cough-Focused Trevi Therapeutics Stock Skyrocketing On Thursday?
December 12, 2024
Trevi Therapeutics' CORAL trial progresses unchanged after a positive SSRE review, with topline results for chronic cough in IPF expected by mid-2025.
Via
Benzinga
TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q2 2024
August 08, 2024
TRVI stock results show that Trevi Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
June 06, 2024
Via
Benzinga
TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q1 2024
May 07, 2024
TRVI stock results show that Trevi Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
TRVI Stock Earnings: Trevi Therapeutics Beats EPS for Q4 2023
March 20, 2024
TRVI stock results show that Trevi Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For March 20, 2024
March 20, 2024
Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 01, 2023
Via
Benzinga
Earnings Scheduled For November 9, 2023
November 09, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 18, 2023
Via
Benzinga
Earnings Scheduled For August 10, 2023
August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Via
Benzinga
Earnings Scheduled For May 11, 2023
May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 18, 2023
Via
Benzinga
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 18, 2023
Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional...
Via
Benzinga
Earnings Scheduled For March 16, 2023
March 16, 2023
Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
April 12, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.